Stay updated on IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page.

Latest updates to the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAn updated revision entry to v3.5.4 was added to the Record History, replacing v3.5.3. This reflects a metadata update to the study record history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe Record History shows a new revision, updating from v3.5.2 to v3.5.3, indicating an updated build of the page. This update reflects a minor update to the page's metadata or presentation without altering study data.SummaryDifference0.1%

- Check37 days agoChange DetectedThe Record History now lists a new revision entry v3.5.2 and removes the older v3.5.0 entry.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.2 was removed from the page.SummaryDifference0.1%

- Check101 days agoChange DetectedAdded a new revision entry (v3.4.2) to the study history and removed the older funding-status notice. These are administrative updates that affect only the history display but not the study content.SummaryDifference0.9%

- Check108 days agoChange DetectedAdded a site-wide notice about government funding lapse and the NIH Clinical Center being open, and updated the study record with Revision: v3.4.1, while removing Revision: v3.4.0.SummaryDifference0.9%

Stay in the know with updates to IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page.